Patent application number | Description | Published |
20090076275 | DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS - Provided herein are compounds of the formula (I): | 03-19-2009 |
20090099201 | Diacylglycerol Acyltransferase Inhibitors - Provided herein are compounds of the formula (I): | 04-16-2009 |
20090105273 | Diacylglycerol Acyltransferase Inhibitors - Provided herein are compounds of the formula (I): | 04-23-2009 |
20090170864 | Diacylglycerol Acyltransferase Inhibitors - Provided herein are compounds of the formula (I): | 07-02-2009 |
20100168419 | Diacylglycerol Acyltransferase Inhibitors - Provided herein are compounds of the formula (I): | 07-01-2010 |
20100190979 | DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS - Provided herein are compounds of the formula (I): | 07-29-2010 |
20110112158 | BENZISOXAZOLE ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS - Provided herein are compounds of the formula (I): | 05-12-2011 |
20110112161 | INDOLE AND INDAZOLE ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS - Provided herein are compounds of the formula (I): | 05-12-2011 |
20110130438 | ANILINE ANALOGS AS GLYCOGEN SYNTHASE ACTIVATORS - Provided herein are compounds of the formula (I): | 06-02-2011 |
20130059834 | PYRROLOPYRAZINE KINASE INHIBITORS - The present invention relates to the use of novel pyrrolopyrazine derivatives of Formula I, | 03-07-2013 |
20130197059 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1 - The invention relates to compounds of formula I: | 08-01-2013 |
20130197205 | CHITOSAN COVALENTLY LINKED WITH SMALL MOLECULE INTEGRIN ANTAGONIST FOR TARGETED DELIVERY - The invention relates to the chitosan polymer derivatives of formula I: | 08-01-2013 |
20150031715 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING VLA-4 - The invention relates to compounds of formula I: wherein R1, R2, and n are defined in the detailed description and claims. In particular, the present invention relates to the compounds of formula I for use in the manufacture and delivery of conjugated moieties such as small molecules, peptides, nucleic acids, fluorescent moieties, and polymers which are linked to VLA-4 integrin antagonists to target cells expressing VLA-4. | 01-29-2015 |
20150038523 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING ALPHA-V-BETA-3 - The invention relates to compounds of formula (I): wherein R | 02-05-2015 |
20150065534 | INTEGRIN ANTAGONIST CONJUGATES FOR TARGETED DELIVERY TO CELLS EXPRESSING LFA-1 - The invention relates to compounds of formula (I), wherein R1, R2, and n are defined in the detailed description and claims. In particular, the present invention relates to the compounds of formula I for use in the manufacture and delivery of conjugated moieties such as small molecules, peptides, nucleic acids, fluorescent moieties, and polymers which are linked to LFA-1 integrin antagonists to target cells expressing LFA-1. | 03-05-2015 |